BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25270712)

  • 1. Regional glucose metabolic reduction in dementia with Lewy bodies is independent of amyloid deposition.
    Ishii K; Hosokawa C; Hyodo T; Sakaguchi K; Usami K; Shimamoto K; Hosono M; Yamazoe Y; Murakami T
    Ann Nucl Med; 2015 Jan; 29(1):78-83. PubMed ID: 25270712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodality imaging characteristics of dementia with Lewy bodies.
    Kantarci K; Lowe VJ; Boeve BF; Weigand SD; Senjem ML; Przybelski SA; Dickson DW; Parisi JE; Knopman DS; Smith GE; Ferman TJ; Petersen RC; Jack CR
    Neurobiol Aging; 2012 Sep; 33(9):2091-105. PubMed ID: 22018896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
    Chiba Y; Fujishiro H; Ota K; Kasanuki K; Arai H; Hirayasu Y; Sato K; Iseki E
    Int J Geriatr Psychiatry; 2015 Mar; 30(3):316-23. PubMed ID: 24839913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amygdala sign, a FDG-PET signature of dementia with Lewy Bodies.
    Pillai JA; Wu G; Tousi B; Larvie M; Léger GC; Leverenz JB
    Parkinsonism Relat Disord; 2019 Jul; 64():300-303. PubMed ID: 30905401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid and glucose imaging in dementia with Lewy bodies and multiple systems atrophy.
    Claassen DO; Lowe VJ; Peller PJ; Petersen RC; Josephs KA
    Parkinsonism Relat Disord; 2011 Mar; 17(3):160-5. PubMed ID: 21195652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
    Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.
    Kantarci K; Lowe VJ; Boeve BF; Senjem ML; Tosakulwong N; Lesnick TG; Spychalla AJ; Gunter JL; Fields JA; Graff-Radford J; Ferman TJ; Jones DT; Murray ME; Knopman DS; Jack CR; Petersen RC
    Ann Neurol; 2017 Jan; 81(1):58-67. PubMed ID: 27863444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns.
    Ye BS; Lee S; Yoo H; Chung SJ; Lee YH; Choi Y; Lee PH; Sohn YH; Yun M
    Neurobiol Aging; 2020 Mar; 87():11-17. PubMed ID: 31791660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
    Spehl TS; Hellwig S; Amtage F; Weiller C; Bormann T; Weber WA; Hüll M; Meyer PT; Frings L
    J Neuroimaging; 2015; 25(2):281-288. PubMed ID: 24593796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two distinct pathological substrates associated with MMSE-pentagons item deficit in DLB and AD.
    Beretta L; Caminiti SP; Santangelo R; Magnani G; Ferrari-Pellegrini F; Caffarra P; Perani D
    Neuropsychologia; 2019 Oct; 133():107174. PubMed ID: 31446008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Alzheimer's Disease and Lewy Body Disease on Metabolic Changes.
    Lee YH; Jeon S; Yoo HS; Chung SJ; Jung JH; Baik K; Sohn YH; Lee PH; Yun M; Evans AC; Ye BS
    J Alzheimers Dis; 2021; 79(4):1471-1487. PubMed ID: 33459638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.
    Edison P; Archer HA; Hinz R; Hammers A; Pavese N; Tai YF; Hotton G; Cutler D; Fox N; Kennedy A; Rossor M; Brooks DJ
    Neurology; 2007 Feb; 68(7):501-8. PubMed ID: 17065593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging beta-amyloid burden in aging and dementia.
    Rowe CC; Ng S; Ackermann U; Gong SJ; Pike K; Savage G; Cowie TF; Dickinson KL; Maruff P; Darby D; Smith C; Woodward M; Merory J; Tochon-Danguy H; O'Keefe G; Klunk WE; Mathis CA; Price JC; Masters CL; Villemagne VL
    Neurology; 2007 May; 68(20):1718-25. PubMed ID: 17502554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging amyloid deposition in Lewy body diseases.
    Gomperts SN; Rentz DM; Moran E; Becker JA; Locascio JJ; Klunk WE; Mathis CA; Elmaleh DR; Shoup T; Fischman AJ; Hyman BT; Growdon JH; Johnson KA
    Neurology; 2008 Sep; 71(12):903-10. PubMed ID: 18794492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy.
    Shimada H; Shinotoh H; Hirano S; Miyoshi M; Sato K; Tanaka N; Ota T; Fukushi K; Irie T; Ito H; Higuchi M; Kuwabara S; Suhara T
    Mov Disord; 2013 Feb; 28(2):169-75. PubMed ID: 23225334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
    Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional expansion of hypometabolism in Alzheimer's disease follows amyloid deposition with temporal delay.
    Förster S; Grimmer T; Miederer I; Henriksen G; Yousefi BH; Graner P; Wester HJ; Förstl H; Kurz A; Dickerson BC; Bartenstein P; Drzezga A
    Biol Psychiatry; 2012 May; 71(9):792-7. PubMed ID: 21679929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography.
    Imai M; Tanaka M; Sakata M; Wagatsuma K; Tago T; Toyohara J; Sengoku R; Nishina Y; Kanemaru K; Ishibashi K; Murayama S; Ishii K
    J Alzheimers Dis; 2020; 73(1):197-207. PubMed ID: 31771066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial metabolic profiles to discriminate dementia with Lewy bodies from Alzheimer disease.
    Iizuka T; Kameyama M
    J Neurol; 2020 Jul; 267(7):1960-1969. PubMed ID: 32170446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.